{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:53:54Z","timestamp":1789422834447,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"crossref","award":["76354"],"award-info":[{"award-number":["76354"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00415-020-09925-x","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T13:02:39Z","timestamp":1590238959000},"page":"2829-2841","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Visual hallucinations and illusions in Parkinson\u2019s disease: the role of ocular pathology"],"prefix":"10.1007","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2428-4899","authenticated-orcid":false,"given":"Ana","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Beze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Chassain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Monneyron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Delaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Derost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9reng\u00e8re","family":"Debilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J. G.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Chiambaretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Durif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,23]]},"reference":[{"key":"9925_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1212\/WNL.0000000000007913","volume":"93","author":"A Lenka","year":"2019","unstructured":"Lenka A, Pagonabarraga J, Pal PK, Bejr-Kasem H, Kulisvesky J (2019) Minor hallucinations in Parkinson disease: a subtle symptom with major clinical implications. Neurology 93:259\u2013266. https:\/\/doi.org\/10.1212\/WNL.0000000000007913","journal-title":"Neurology"},{"issue":"Pt 4","key":"9925_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/brain\/123.4.733","volume":"123","author":"G F\u00e9nelon","year":"2000","unstructured":"F\u00e9nelon G, Mahieux F, Huon R, Zi\u00e9gler M (2000) Hallucinations in Parkinson\u2019s disease: prevalence, phenomenology and risk factors. Brain 123(Pt 4):733\u2013745","journal-title":"Brain"},{"key":"9925_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/01.wnl.0000103444.45882.d8","volume":"62","author":"V Biousse","year":"2004","unstructured":"Biousse V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ (2004) Ophthalmologic features of Parkinson\u2019s disease. Neurology 62:177\u2013180. https:\/\/doi.org\/10.1212\/01.wnl.0000103444.45882.d8","journal-title":"Neurology"},{"key":"9925_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.26432","volume":"31","author":"J Pagonabarraga","year":"2016","unstructured":"Pagonabarraga J, Martinez-Horta S, Fern\u00e1ndez de Bobadilla R, P\u00e9rez J, Ribosa-Nogu\u00e9 R, Mar\u00edn J, Pascual-Sedano B, Garc\u00eda C, Gironell A, Kulisevsky J (2016) Minor hallucinations occur in drug-naive Parkinson\u2019s disease patients, even from the premotor phase. Mov Disord 31:45\u201352. https:\/\/doi.org\/10.1002\/mds.26432","journal-title":"Mov Disord"},{"key":"9925_CR5","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1001\/jama.218.13.1915","volume":"218","author":"FK Goodwin","year":"1971","unstructured":"Goodwin FK (1971) Psychiatric side effects of levodopa in man. JAMA J Am Med Assoc 218:1915\u20131920. https:\/\/doi.org\/10.1001\/jama.218.13.1915","journal-title":"JAMA J Am Med Assoc"},{"key":"9925_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1212\/wnl.51.3.811","volume":"51","author":"CG Goetz","year":"1998","unstructured":"Goetz CG, Vogel C, Tanner CM, Stebbins GT (1998) Early dopaminergic drug-induced hallucinations in parkinsonian patients. Neurology 51:811\u2013814. https:\/\/doi.org\/10.1212\/wnl.51.3.811","journal-title":"Neurology"},{"key":"9925_CR7","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1212\/WNL.0b013e3181fd6158","volume":"75","author":"CG Goetz","year":"2010","unstructured":"Goetz CG, Ouyang B, Negron A, Stebbins GT (2010) Hallucinations and sleep disorders in PD: 10-year prospective longitudinal study. Neurology 75:1773\u20131779. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fd6158","journal-title":"Neurology"},{"key":"9925_CR8","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/mds.20965","volume":"21","author":"B Ram\u00edrez-Ruiz","year":"2006","unstructured":"Ram\u00edrez-Ruiz B, Junqu\u00e9 C, Mart\u00ed M-J, Valldeoriola F, Tolosa E (2006) Neuropsychological deficits in Parkinson\u2019s disease patients with visual hallucinations. Mov Disord 21:1483\u20131487. https:\/\/doi.org\/10.1002\/mds.20965","journal-title":"Mov Disord"},{"key":"9925_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/jnnp.2007.116202","volume":"79","author":"J Barnes","year":"2008","unstructured":"Barnes J, Boubert L (2008) Executive functions are impaired in patients with Parkinson\u2019s disease with visual hallucinations. J Neurol Neurosurg Psychiatry 79:190\u2013192. https:\/\/doi.org\/10.1136\/jnnp.2007.116202","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9925_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mds.25543","volume":"29","author":"J-Y Lee","year":"2014","unstructured":"Lee J-Y, Kim JM, Ahn J, Kim H-J, Jeon BS, Kim TW (2014) Retinal nerve fiber layer thickness and visual hallucinations in Parkinson\u2019s disease. Mov Disord 29:61\u201367. https:\/\/doi.org\/10.1002\/mds.25543","journal-title":"Mov Disord"},{"key":"9925_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10072-014-1930-2","volume":"36","author":"I \u0160tenc Bradvica","year":"2015","unstructured":"\u0160tenc Bradvica I, Bradvica M, Mati\u0107 S, Reisz-Maji\u0107 P (2015) Visual dysfunction in patients with Parkinson\u2019s disease and essential tremor. Neurol Sci 36:257\u2013262. https:\/\/doi.org\/10.1007\/s10072-014-1930-2","journal-title":"Neurol Sci"},{"key":"9925_CR12","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/mds.23891","volume":"26","author":"NK Archibald","year":"2011","unstructured":"Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2011) Visual symptoms in Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Mov Disord 26:2387\u20132395. https:\/\/doi.org\/10.1002\/mds.23891","journal-title":"Mov Disord"},{"key":"9925_CR13","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/mds.27454","volume":"33","author":"L Guo","year":"2018","unstructured":"Guo L, Normando EM, Shah PA, De Groef L, Cordeiro MF (2018) Oculo-visual abnormalities in Parkinson\u2019s disease: possible value as biomarkers. Mov Disord 33:1390\u20131406. https:\/\/doi.org\/10.1002\/mds.27454","journal-title":"Mov Disord"},{"key":"9925_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.parkreldis.2013.12.009","volume":"20","author":"P Urwyler","year":"2014","unstructured":"Urwyler P, Nef T, Killen A, Collerton D, Thomas A, Burn D, McKeith I, Mosimann UP (2014) Visual complaints and visual hallucinations in Parkinson\u2019s disease. Parkinsonism Relat Disord 20:318\u2013322. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.12.009","journal-title":"Parkinsonism Relat Disord"},{"key":"9925_CR15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awp068","volume":"132","author":"NK Archibald","year":"2009","unstructured":"Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2009) The retina in Parkinson\u2019s disease. Brain 132:1128\u20131145. https:\/\/doi.org\/10.1093\/brain\/awp068","journal-title":"Brain"},{"key":"9925_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/jnnp-2019-322702","volume":"91","author":"J O\u2019Brien","year":"2020","unstructured":"O\u2019Brien J, Taylor JP, Ballard C, Barker RA, Bradley C, Burns A, Collerton D, Dave S, Dudley R, Francis P, Gibbons A, Harris K, Lawrence V, Leroi I, McKeith I, Michaelides M, Naik C, O\u2019Callaghan C, Olsen K, Onofrj M, Pinto R, Russell G, Swann P, Thomas A, Urwyler P, Weil RS, Ffytche D (2020) Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management. J Neurol Neurosurg Psychiatry 91:512\u2013519. https:\/\/doi.org\/10.1136\/jnnp-2019-322702","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9925_CR17","doi-asserted-by":"publisher","first-page":"e1539","DOI":"10.1212\/WNL.0000000000009214","volume":"94","author":"CDJM Borm","year":"2020","unstructured":"Borm CDJM, Visser F, Werkmann M, de Graaf D, Putz D, Seppi K, Poewe W, Vlaar AMM, Hoyng C, Bloem BR, Theelen T, de Vries NM (2020) Seeing ophthalmologic problems in Parkinson disease: results of a visual impairment questionnaire. Neurology 94:e1539\u2013e1547. https:\/\/doi.org\/10.1212\/WNL.0000000000009214","journal-title":"Neurology"},{"key":"9925_CR18","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/mds.21696","volume":"22","author":"M Visser","year":"2007","unstructured":"Visser M, Verbaan D, van Rooden SM, Stiggelbout AM, Marinus J, van Hilten JJ (2007) Assessment of psychiatric complications in Parkinson\u2019s disease: the SCOPA-PC. Mov Disord 22:2221\u20132228. https:\/\/doi.org\/10.1002\/mds.21696","journal-title":"Mov Disord"},{"key":"9925_CR19","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.8.5.6","author":"BM Wong","year":"2019","unstructured":"Wong BM, Cheng RW, Mandelcorn ED, Margolin E, El-Defrawy S, Yan P, Santiago AT, Leontieva E, Lou W, ONDRI Investigators, Hatch W, Hudson C (2019) Validation of optical coherence tomography retinal segmentation in neurodegenerative disease. Transl Vis Sci Technol. https:\/\/doi.org\/10.1167\/tvst.8.5.6","journal-title":"Transl Vis Sci Technol"},{"key":"9925_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.neuropsychologia.2009.08.021","volume":"48","author":"AW Ellis","year":"2010","unstructured":"Ellis AW, Brysbaert M (2010) Split fovea theory and the role of the two cerebral hemispheres in reading: a review of the evidence. Neuropsychologia 48:353\u2013365. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2009.08.021","journal-title":"Neuropsychologia"},{"key":"9925_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ophtha.2017.01.004","volume":"124","author":"A Yarmohammadi","year":"2017","unstructured":"Yarmohammadi A, Zangwill LM, Diniz-Filho A, Saunders LJ, Suh MH, Wu Z, Manalastas PIC, Akagi T, Medeiros FA, Weinreb RN (2017) Peripapillary and macular vessel density in patients with glaucoma and single-hemifield visual field defect. Ophthalmology 124:709\u2013719. https:\/\/doi.org\/10.1016\/j.ophtha.2017.01.004","journal-title":"Ophthalmology"},{"key":"9925_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.schres.2014.11.010","volume":"161","author":"I de Chazeron","year":"2015","unstructured":"de Chazeron I, Pereira B, Chereau-Boudet I, Brousse G, Misdrahi D, F\u00e9nelon G, Tronche A-M, Schwan R, Lan\u00e7on C, Marques A, Debilly B, Durif F, Llorca PM (2015) Validation of a Psycho-Sensory hAllucinations Scale (PSAS) in schizophrenia and Parkinson\u2019s disease. Schizophr Res 161:269\u2013276. https:\/\/doi.org\/10.1016\/j.schres.2014.11.010","journal-title":"Schizophr Res"},{"key":"9925_CR23","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 25:2649\u20132653. https:\/\/doi.org\/10.1002\/mds.23429","journal-title":"Mov Disord"},{"key":"9925_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1076\/jcen.20.2.211.1169","volume":"20","author":"LJ Rapport","year":"1998","unstructured":"Rapport LJ, Millis SR, Bonello PJ (1998) Validation of the Warrington theory of visual processing and the visual object and space perception battery. J Clin Exp Neuropsychol 20:211\u2013220. https:\/\/doi.org\/10.1076\/jcen.20.2.211.1169","journal-title":"J Clin Exp Neuropsychol"},{"key":"9925_CR25","volume-title":"Protocole Montr\u00e9al Toulouse d\u2019Evaluation des Gnosies Visuelles PEGV","author":"A Agniel","year":"1992","unstructured":"Agniel A, Joanette Y, Doyon B, Duchein C (1992) Protocole Montr\u00e9al Toulouse d\u2019Evaluation des Gnosies Visuelles PEGV. Ortho-Edition, Isberg"},{"key":"9925_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/jnnp.73.6.629","volume":"73","author":"KR Chaudhuri","year":"2002","unstructured":"Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, H\u00f6gl B, Trenkwalder C (2002) The Parkinson\u2019s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatr 73:629\u2013635","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"9925_CR27","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/mds.25037","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma RB, Arnulf I, Hogl B, Iranzo A, Miyamoto T, Dauvilliers Y, Oertel W, Ju Y-E, Puligheddu M, Jennum P, Pelletier A, Wolfson C, Leu-Semenescu S, Frauscher B, Miyamoto M, Cochen De Cock V, Unger MM, Stiasny-Kolster K, Fantini ML, Montplaisir JY (2012) A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov Disord 27:913\u2013916. https:\/\/doi.org\/10.1002\/mds.25037","journal-title":"Mov Disord"},{"key":"9925_CR28","doi-asserted-by":"publisher","first-page":"709191","DOI":"10.1155\/2015\/709191","volume":"2015","author":"A Kopal","year":"2015","unstructured":"Kopal A, Mejzl\u00edkov\u00e1 E, Preiningerov\u00e1 JL, Brebera D, Ulmanov\u00e1 O, Ehler E, Roth J (2015) Changes of retina are not involved in the genesis of visual hallucinations in Parkinson\u2019s disease. Parkinsons Dis 2015:709191. https:\/\/doi.org\/10.1155\/2015\/709191","journal-title":"Parkinsons Dis"},{"key":"9925_CR29","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1093\/brain\/awp223","volume":"132","author":"AM Meppelink","year":"2009","unstructured":"Meppelink AM, de Jong BM, Renken R, Leenders KL, Cornelissen FW, van Laar T (2009) Impaired visual processing preceding image recognition in Parkinson\u2019s disease patients with visual hallucinations. Brain 132:2980\u20132993. https:\/\/doi.org\/10.1093\/brain\/awp223","journal-title":"Brain"},{"key":"9925_CR30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1468-1331.2007.01768.x","volume":"14","author":"B Ram\u00edrez-Ruiz","year":"2007","unstructured":"Ram\u00edrez-Ruiz B, Mart\u00ed M-J, Tolosa E, Gim\u00e9nez M, Bargall\u00f3 N, Valldeoriola F, Junqu\u00e9 C (2007) Cerebral atrophy in Parkinson\u2019s disease patients with visual hallucinations. Eur J Neurol 14:750\u2013756. https:\/\/doi.org\/10.1111\/j.1468-1331.2007.01768.x","journal-title":"Eur J Neurol"},{"key":"9925_CR31","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/jnnp.2009.179655","volume":"81","author":"N Ibarretxe-Bilbao","year":"2010","unstructured":"Ibarretxe-Bilbao N, Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola F, Bargallo N, Juanes S, Tolosa E (2010) Differential progression of brain atrophy in Parkinson\u2019s disease with and without visual hallucinations. J Neurol Neurosurg Psychiatry 81:650\u2013657. https:\/\/doi.org\/10.1136\/jnnp.2009.179655","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9925_CR32","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/brain\/awf251","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson\u2019s disease. Brain 125:2431\u20132445. https:\/\/doi.org\/10.1093\/brain\/awf251","journal-title":"Brain"},{"key":"9925_CR33","first-page":"289","volume":"21","author":"NJ Diederich","year":"1998","unstructured":"Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V (1998) Poor visual discrimination and visual hallucinations in Parkinson\u2019s disease. Clin Neuropharmacol 21:289\u2013295","journal-title":"Clin Neuropharmacol"},{"key":"9925_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/0891988705284739","volume":"19","author":"H Matsui","year":"2006","unstructured":"Matsui H, Udaka F, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M (2006) Impaired visual acuity as a risk factor for visual hallucinations in Parkinson\u2019s disease. J Geriatr Psychiatry Neurol 19:36\u201340. https:\/\/doi.org\/10.1177\/0891988705284739","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"9925_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0028-3932(02)00182-3","volume":"41","author":"J Barnes","year":"2003","unstructured":"Barnes J, Boubert L, Harris J, Lee A, David AS (2003) Reality monitoring and visual hallucinations in Parkinson\u2019s disease. Neuropsychologia 41:565\u2013574","journal-title":"Neuropsychologia"},{"key":"9925_CR36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mds.20308","volume":"20","author":"NJ Diederich","year":"2005","unstructured":"Diederich NJ, Goetz CG, Stebbins GT (2005) Repeated visual hallucinations in Parkinson\u2019s disease as disturbed external\/internal perceptions: focused review and a new integrative model. Mov Disord 20:130\u2013140. https:\/\/doi.org\/10.1002\/mds.20308","journal-title":"Mov Disord"},{"key":"9925_CR37","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26004","volume":"29","author":"AJ Muller","year":"2014","unstructured":"Muller AJ, Shine JM, Halliday GM, Lewis SJG (2014) Visual hallucinations in Parkinson\u2019s disease: theoretical models. Mov Disord 29:1591\u20131598. https:\/\/doi.org\/10.1002\/mds.26004","journal-title":"Mov Disord"},{"key":"9925_CR38","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1017\/S0140525X05000130","volume":"28","author":"D Collerton","year":"2005","unstructured":"Collerton D, Perry E, McKeith I (2005) Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations. Behav Brain Sci 28:737\u2013757. https:\/\/doi.org\/10.1017\/S0140525X05000130","journal-title":"Behav Brain Sci"},{"key":"9925_CR39","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/mds.23896","volume":"26","author":"JM Shine","year":"2011","unstructured":"Shine JM, Halliday GM, Naismith SL, Lewis SJG (2011) Visual misperceptions and hallucinations in Parkinson\u2019s disease: dysfunction of attentional control networks? Mov Disord 26:2154\u20132159. https:\/\/doi.org\/10.1002\/mds.23896","journal-title":"Mov Disord"},{"key":"9925_CR40","doi-asserted-by":"publisher","first-page":"36284","DOI":"10.1038\/srep36284","volume":"6","author":"S Lefebvre","year":"2016","unstructured":"Lefebvre S, Baille G, Jardri R, Plomhause L, Szaffarczyk S, Defebvre L, Thomas P, Delmaire C, Pins D, Dujardin K (2016) Hallucinations and conscious access to visual inputs in Parkinson\u2019s disease. Sci Rep 6:36284. https:\/\/doi.org\/10.1038\/srep36284","journal-title":"Sci Rep"},{"key":"9925_CR41","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.bpsc.2017.04.007","volume":"2","author":"C O\u2019Callaghan","year":"2017","unstructured":"O\u2019Callaghan C, Hall JM, Tomassini A, Muller AJ, Walpola IC, Moustafa AA, Shine JM, Lewis SJG (2017) Visual hallucinations are characterized by impaired sensory evidence accumulation: insights from hierarchical drift diffusion modeling in Parkinson\u2019s disease. Biol Psychiatry Cogn Neurosci Neuroimaging 2:680\u2013688. https:\/\/doi.org\/10.1016\/j.bpsc.2017.04.007","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"9925_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.parkreldis.2013.11.017","volume":"20","author":"J Pagonabarraga","year":"2014","unstructured":"Pagonabarraga J, Soriano-Mas C, Llebaria G, L\u00f3pez-Sol\u00e0 M, Pujol J, Kulisevsky J (2014) Neural correlates of minor hallucinations in non-demented patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 20:290\u2013296. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.11.017","journal-title":"Parkinsonism Relat Disord"},{"key":"9925_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000448517","volume":"17","author":"W-W Lee","year":"2017","unstructured":"Lee W-W, Yoon EJ, Lee J-Y, Park S-W, Kim YK (2017) Visual hallucination and pattern of brain degeneration in Parkinson\u2019s disease. Neurodegener Dis 17:63\u201372. https:\/\/doi.org\/10.1159\/000448517","journal-title":"Neurodegener Dis"},{"key":"9925_CR44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.parkreldis.2018.05.023","volume":"55","author":"Y Nishio","year":"2018","unstructured":"Nishio Y, Yokoi K, Hirayama K, Ishioka T, Hosokai Y, Gang M, Uchiyama M, Baba T, Suzuki K, Takeda A, Mori E (2018) Defining visual illusions in Parkinson\u2019s disease: Kinetopsia and object misidentification illusions. Parkinsonism Relat Disord 55:111\u2013116. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.05.023","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09925-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-09925-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09925-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T23:18:24Z","timestamp":1621725504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-09925-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,23]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["9925"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09925-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,23]]},"assertion":[{"value":"9 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ana Marques, Steven Beze, Bruno Pereira, Carine Chassain, Nathalie Monneyron, Laure Delaby, Celine Lambert, Marie Fontaine, Philippe Derost, B\u00e9reng\u00e8re Debilly, Isabelle Rieu, Simon Lewis, Fr\u00e9d\u00e9ric Chiambaretta, Franck Durif\u2014report no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The protocol was approved by the South-West and Overseas II ethical committee, France (clinicaltrials.gov number NTC03454269).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"All patients gave their written informed consent as per the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}